Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 2;15(1):22716.
doi: 10.1038/s41598-025-09166-w.

PGL-EXPO feasibility study of exposure to SDHi fungicides and risk of hereditary SDHx paraganglioma or pheochromocytoma

Affiliations

PGL-EXPO feasibility study of exposure to SDHi fungicides and risk of hereditary SDHx paraganglioma or pheochromocytoma

Astrid Coste et al. Sci Rep. .

Abstract

Paraganglioma and pheochromocytoma (PPGL) are rare neuroendocrine tumors with a strong genetic component. SDHx genes are well-known PPGL susceptibility genes. A role of environmental factors, such as succinate dehydrogenase inhibitor (SDHi) fungicides, is suspected in PPGL tumorigenesis. We evaluated the feasibility of a case-control study investigating the association between pesticides, focusing on SDHi fungicides, and the risk of SDHx-related PPGL. The study was conducted in a single referral center between March and June 2022. Cases were patients with PPGL and an SDHx germline mutation diagnosed between 2000 and 2021. Controls, were selected among relatives of cases, diagnosed as SDHx mutation carriers by a presymptomatic genetic test and without PPGL after tumor screening tests. A matching process was formulated to prioritize cases and controls that could be matched according to date of birth, type of gene mutated and distinct family. Phone interviews were used to collect data on general characteristics, PPGL risk factors, the domestic use of pesticides, residential history, occupational history. Addresses were geocoded. The presence of crops within a buffer of 1,500 m was estimated for residential addresses at diagnosis. The probability of occupational exposures to SDHi fungicides was assessed based on the French crop-exposure matrix PESTIMAT. An information letter was sent to 138 subjects out of the 193 followed-up by the center. The prioritization of recruitment was defined by the matching potential of each subject. Overall, 110 subjects were reached by phone, 101 accepted to be included, and 42 cases and 40 controls were interviewed (response rate: 81%). Missing data on domestic exposure to pesticides were more frequent for the households most back-in-time. Even for the oldest residential addresses, at least 81% of the addresses had a precise geocoding. In a buffer with a radius of 1500 m, arable land was present for 55% of subjects' addresses, vineyards and orchards for 5% and 3.8% respectively. Two subjects might have been exposed to SDHi fungicides in the occupational context. Our study showed high participation and response rates. Exposure to pesticides could be assessed with moderate to good precision, even for exposures far back in time.

Keywords: Case-control study; Feasibility study; Hereditary paraganglioma; SDH gene; SDHi fungicides.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Ethics and legal aspects: French law (in accordance with Articles L1122-1 and L1122-1-1 of the French Public Health Code) requires that participation in research of this nature (non-interventional epidemiological study) be offered to patients after they have been individually informed in writing, with the physician seeking the patient’s opposition to participation, and ensuring traceability of the absence of opposition (“non-objection form”). The law does not require written traceability to be directly ensured by the patient. These procedures have been implemented for this study (PGL.EXPO-1-ClinicalTrials.gov Identifier: NCT04481152) after approval by a committee for the protection of persons, in accordance with the law (Protection of Persons Committee of Ile-de-France X, Ref: 34-2020). It also received a favorable opinion from the French data protection authority, the Commission Nationale Informatique et Libertés (CNIL) (Ref: MLD/MFI/AR2114411). More specifically, before being included in the study, the patient receives a written information. The investigator orally explains to the patient the content of this information note, which consists of presenting the study, explaining its objectives and answering any questions the patient may have. The patient’s consent is given orally to the investigator, following the various items of information provided by the investigator, i.e. “informed consent”, who attests to this on the information note by indicating the following 4 items of information: patient’s surname/first name/identifier in the research; opposition expressed, date of issue of information, signature of person responsible for information.

Figures

Fig. 1
Fig. 1
Flow chart of the participants in PGL-EXPO-1. Case-control, monocentric pilot study, Georges Pompidou European Hospitala, Paris, 2022.
Fig. 2
Fig. 2
Variations of case/control pairs formed according to the hypothesis on the mutated gene, based on 10 000 iterations.
Fig. 3
Fig. 3
Pesticide use (yes/no) in the household at the time of the interview, overall, by type of pests they target and type of use.
Fig. 4
Fig. 4
Evolution of missing data over time for domestic use of pesticides. The vertical axis of the graph represents the characteristics associated with domestic use of pesticides overall, by type of pests they target, and by type of use. At the top of the horizontal axis is the dwelling/housing number with, on the left, the dwelling at interview and on the right the dwelling at birth. At the bottom is the number of subjects concerned for each dwelling. For example, « n = 48 » means that 48 subjects declared at least 7 dwellings between their birth and the interview.
Fig. 5
Fig. 5
Distribution of participants’ addresses according to the precision category of the geocoding and the decade.

Similar articles

References

    1. Berends, A. M. A. et al. Incidence of pheochromocytoma and sympathetic paraganglioma in the netherlands: A nationwide study and systematic review. Eur. J. Intern. Med.51, 68–73 (2018). - PubMed
    1. Leung, A. A., Hyrcza, M. D., Pasieka, J. L. & Kline, G. A. Incidence of pheochromocytoma and paraganglioma varies according to altitude: meta-regression analysis. Eur. J. Endocrinol.184, L21–L23 (2021). - PubMed
    1. Stenström, G. & Svårdsudd, K. Pheochromocytoma in Sweden 1958–1981: an analysis of the National Cancer registry data. Acta Med. Scand.220, 225–232 (1986). - PubMed
    1. Gimenez-Roqueplo, A. P., Robledo, M. & Dahia, P. L. M. Update on the genetics of paragangliomas. Endocr. Relat. Cancer. 30, e220373 (2023). - PMC - PubMed
    1. Lenders, J. W. M. et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab.99, 1915–1942 (2014). - PubMed

MeSH terms

Substances

LinkOut - more resources